pJL-SaBE3 Citations (2)
Originally described in: Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR Nat Biotechnol. 2017 Feb 13. doi: 10.1038/nbt.3803. PubMed Journal
Articles Citing pJL-SaBE3
| Articles |
|---|
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing.
Liu Z, Lu Z, Yang G, Huang S, Li G, Feng S, Liu Y, Li J, Yu W, Zhang Y, Chen J, Sun Q, Huang X.
Nat Commun. 2018 Jun 14;9(1):2338. doi: 10.1038/s41467-018-04768-7.
PubMed
Associated Plasmids |
| Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant. Tran MTN, Khalid MKNM, Pebay A, Cook AL, Liang HH, Wong RCB, Craig JE, Liu GS, Hung SS, Hewitt AW. Mol Vis. 2019 Mar 16;25:174-182. eCollection 2019. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.